Medigene AG Expands Patent Portfolio for its End-to-End Platform

3 years ago

Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and…

Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology

3 years ago

Vanderbilt Medical Center May 22, 2023 Amsterdam, the Netherlands and Nashville, TN, USA – Royal Philips (NYSE: PHG, AEX: PHIA),…

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

3 years ago

BBS-Bioactive Bone Substitutes Plc, Company announcement, 22 May 2023 4:00 p.m. BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant…

Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference

3 years ago

LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…

Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference

3 years ago

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) Chairman and Chief Executive…

Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors

3 years ago

– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024 –– Financing led by Avidity…

Lumos Pharma to Participate in World Orphan Drug Congress USA

3 years ago

AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate…

Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023

3 years ago

PALO ALTO, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento…

FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients

3 years ago

XBiotech Believes its Drug Candidate Natrunix Could Revolutionize Arthritis TreatmentAUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT)…

Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels

3 years ago

VANCOUVER, British Columbia, May 22, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leader in natural and…